German lawmakers drag pricing freeze out to 2017

The German government has decided to extend a drug-pricing freeze through 2017. Originally set to expire at the end of last year, the pricing policy is just one of the spending moves that has crimped pharma's sales in that country. Legislators also voted to base wholesaler and pharmacy margins on negotiated drug prices, which would publicize discounts on drug brands, allowing other countries to press for lower prices as well. Report

Suggested Articles

The future may be uncertain for AZ’s Imfinzi in first-line lung cancer, but its targeted med Tagrisso now boasts a green light in that setting.

Ultragenyx is back with another FDA nod, this time for Crysvita to treat X-linked hypophosphatemia in patients one year and older.

Roche got a two pieces of good Hemlibra news early this week—and what's good for Hemlibra must be good for Roche.